Filing
Spy
Filing
Spy
Home
About
TALS
Talaris Therapeutics Inc
Biotechnology company focused on cell therapy
CUSIP: 87410C104
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2022 Q1
5 of 8 quarters
Total Value
$32.37M
Total Shares
3.29M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$32.37M
3.29M
0.1%
Unchanged
Viking Global Investors
$32.37M
3.29M shares
Unchanged
TALS — Talaris Therapeutics Inc - FilingSpy